Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation

BACKGROUND: Recent evidence cautions against the use of non-selective beta-blockers (NSBB) in patients with refractory ascites or spontaneous bacterial peritonitis while other data suggests a survival benefit in patients with advanced liver disease. The aim of this study was to describe the use and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Gastroenterol
Hlavní autoři: Ngwa, Taiwo, Orman, Eric, Gomez, Eduardo Vilar, Vuppalanchi, Raj, Kubal, Chandrashekhar, Chalasani, Naga, Ghabril, Marwan
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6945622/
https://ncbi.nlm.nih.gov/pubmed/31906860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-019-1155-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky